Atlas Trials

Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer

Clinical trial NCT06280508 · RECRUITING

Trial details

NCT number
NCT06280508
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence
Start date
2024-03-01
Primary completion
2027-03-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.